Pfizer to continue with manufacturing cuts
US drug giant Pfizer plans to close or sell off an additional 13 manufacturing facilities as part of an effort to cut its number of production plants to 44 by the end of 2009.
US drug giant Pfizer plans to close or sell off an additional 13 manufacturing facilities as part of an effort to cut its number of production plants to 44 by the end of 2009.
You'll be unlikely to see them at your local cinema, but molecular animations created using highly accurate information from X-ray scattering images, will help explain how proteins and organic molecules behave in a solution.
Chiltern has become the latest in a growing number of contract research organisations (CROs) to establish a foothold within the clinical sleeping giant that is Russia.
Germany-based Gene Bridges has licensed its Red/ET Recombineering technology to Novozymes for genetically engineering recombinant micro-organisms for use in industrial applications.
The US Food and Drug Administration (FDA) has revealed it will be operating on the ground in China imminently, while the Drug Information Association (DIA) has just planted itself in Asia's other pharma don, India.